Covered Indications for Adults
Covered adult indications are determined under the current MCG A-0973 criteria, subject to the limitations in this policy.
ALL of the following
The member meets the current MCG A-0973 covered-indication criteria for adults.
All applicable limitations, contraindications, place-of-service requirements, and provider-qualification requirements in this policy are satisfied.
Covered Indications for Adolescents
Covered adolescent indications are determined under the current MCG A-0973 criteria, subject to the limitations in this policy.
ALL of the following
The member meets the current MCG A-0973 covered-indication criteria for adolescents.
All applicable limitations, contraindications, place-of-service requirements, and provider-qualification requirements in this policy are satisfied.
Place of Service and Provider Qualifications
Hypoglossal nerve stimulation for the treatment of obstructive sleep apnea must be furnished in accordance with accepted standards of medical practice and in a setting appropriate to the patient's medical needs and condition.
ALL of the following
The procedure is furnished in an appropriate place of service consistent with the patient's medical needs and condition and accepted standards of medical practice.
Insertion is performed by a qualified physician (MD or DO) who is board certified or board eligible in otolaryngology, has completed an appropriate AMA- or AOA-certified residency and/or fellowship program, and maintains ongoing certification in otolaryngology.
Before implanting an FDA-approved device, the surgeon has completed classroom instruction from the FDA-approved device manufacturer or equivalent and cadaver training in device-implant techniques; documentation of satisfactory training completion is maintained for review.
Sleep physicians and sleep technicians who evaluate, refer, perform post-implant evaluation, or titrate the device have completed appropriate classroom and hands-on training, and documentation of satisfactory training completion or board-approved competency is maintained for review.
Current MCG A-0973 Criteria
Presbyterian Health Plan follows the current MCG A-0973 criteria for both adult and adolescent hypoglossal nerve stimulation coverage, subject to the limitations in this policy.
ALL of the following
The member meets the applicable current MCG A-0973 covered-indication criteria for adults or adolescents, as applicable.
The applicable MCG A-0973 criteria are applied together with the limitations, contraindications, place-of-service requirements, and provider-qualification requirements stated in this policy.
Hypoglossal nerve neurostimulation is not medically reasonable and necessary for all indications other than the covered adult and adolescent indications determined under the current MCG A-0973 criteria and the requirements of this policy.
Non-FDA-approved hypoglossal nerve neurostimulation is not medically reasonable and necessary for the treatment of adult obstructive sleep apnea because of insufficient evidence that it is safe and effective.
Central and mixed apneas comprise more than one-quarter of the total apnea-hypopnea index (AHI).
An implantable device could experience unintended interaction with the hypoglossal nerve stimulation (HGNS) implant system.
For adults, body mass index (BMI) is equal to or greater than 40.
Neuromuscular disease; hypoglossal-nerve palsy; severe restrictive or obstructive pulmonary disease; moderate-to-severe pulmonary arterial hypertension; severe valvular heart disease; or New York Heart Association class III or IV heart failure.
Recent myocardial infarction or severe cardiac arrhythmias within the past 6 months, or persistent uncontrolled hypertension despite medication use.
Active, serious mental illness that reduces the ability to perform activities of daily living (ADLs) and could interfere with the patient's ability to operate the HNS and report problems to the attending provider.
Coexisting nonrespiratory sleep disorders that would confound functional sleep assessment.
The member is pregnant or plans to become pregnant.
The member requires magnetic resonance imaging (MRI) with model 3024. Members requiring MRI with model 3028 may undergo MRI of the head and extremities only when the conditions and precautions in the manufacturer guidelines are met; manufacturer guidelines for this and future models must be followed.
The member is unable, or lacks the necessary assistance, to operate the sleep remote.
A condition or procedure has compromised neurological control of the upper airway.
An anatomical finding could compromise device performance, such as tonsil size 3 or 4 according to the tonsillar hypertrophy grading scale.
Coverage is limited to the covered adult and adolescent indications under the current MCG A-0973 criteria and the applicable requirements of this policy.
Any service that does not satisfy the applicable medical-necessity criteria, contraindication exclusions, place-of-service requirements, or provider-qualification requirements is not reasonable and necessary and will be denied.
Post-Implantation Sleep Studies
One sleep study after hypoglossal nerve implantation is allowed. Any additional post-implantation sleep study requires Medical Director Review (MDR) for medical necessity.
ALL of the following
No more than one sleep study is performed after hypoglossal nerve implantation without additional review.
Any additional post-implantation sleep study is submitted for MDR review and supported by documentation of medical necessity.